First Berlin Equity Research GmbH’s Post

Epoch 41: Understanding Private Biotech VC Returns Learn our language 👇 👉DPI (Distributions to Paid-In Capital) 👉Net Cash Flows 👉TVPI (Total Value to Paid-In) 👉IRR (Internal Rate of Return) 👉AUM (Assets Under Mgmt) 👉Exit & Vintage Analysis https://lnkd.in/dEkBy2bY

"How do I know the true value of my business?" is a question I am often asked. Valuing a biotech company involves more than just financial metrics. It’s a comprehensive process that looks at three key dimensions that together form the Concluded Value. By evaluating these factors, investors and stakeholders can get a clearer picture of a company's worth and growth potential in the biotech sector. This approach ensures that both current performance and future prospects are taken into account, paving the way for more informed decisions. If you are considering an exit strategy and want to know the value of your company feel free to arrange a call. #FinancialAnalysis #BusinessStrategy #BiotechValuation #Biotech

For anyone in biotech thinking about an exit strategy, getting an accurate valuation helps lay the groundwork for confident decision-making. Get in touch if you'd like to discuss what factors can impact your company’s value. #BiotechValuation #StrategicGrowth #BusinessValuation #LifeSciences

Exposure to innovative and transformative biotech companies has been a part of Pinnacle’s SMID investment strategy since our portfolio’s inception in 1996. Our latest white paper entitled “Biotechnology: Do Not Be Afraid” is authored by Kimon Passios, an Executive Vice President and a member of our Investment Team. Read more here -  https://lnkd.in/ekrbH8-x #biotech #investments #investors #stocks #finance

At face value some of the reported Series B and C metrics in recent quarters look quite encouraging, but if you dig a little bit the story is more complex. Although capital deployed is recovering, it remains difficult to acquire and highly concentrated in substantially fewer deals than both the pandemic and the period immediately before it. Valuations also appear comparatively strong in B and C rounds, which is good news for the funded despite deals taking noticeably longer to get funded. #Biotech #VentureCapital #Valuation

Nalka and Kirk Kapital, two investment firms, agreed to acquire Norstat, a data collectors for market research and insight, from Triton Partners, a private equity firm. Financial terms were not disclosed. "Norstat is truly a leading company within its market, that we have followed over time. We are impressed by the team and its position as the go-to provider of high-quality data and insights in Europe. The deal is pending regulatory approval, but we are looking forward to our future cooperation with Norstat and to contribute to the company's development. We are also glad to partner with Kirk Kapital as a large minority shareholder, a strong partner sharing our values and long-term perspective on business development," Martin Lagerblad, Nalka Invest Managing Director. Triton (led by Daniel Björklund) is advised by William Blair. Norstat is led by Erling Eriksen. Nalka Invest is led by Martin Lagerblad. Kirk Kapital is led by Kim Gulstad. #MergersAcquisitionsDivestitures #MarketResearch #Data

Epoch 33: How the Biggest Investors in Biotech Have Been Behaving 👉2H Macro Forecast 👉IRA Updates 👉Public / Private Biotech Investor Trends https://lnkd.in/dEkBy2bY

Discover how Biotech ETFs like $XBI, $BBC, and $SBIO are outperforming in 2024, charting significant gains, while small-cap tech struggles to keep pace in the current market landscape. #Biotech #ETFs #InvestmentTrends #MarketInsights #IT #CIO #technology https://lnkd.in/gK_EwTuf

Shake Hands with the Sell Side: Communicating with Analysts and Investors Biocom California has assembled some of the top industry analysts to share insights on the evolving role of equity research analysts, current market trends, and best practices for communicating with your analysts as well as investors in this panel discussion on October 1st. Jointly sponsored by Sayva Solutions, we hope you can join us for this insightful discussion. #biocomca #equityanalysts #equityresearch #investors #investmentfunding #funding

Have you seen the message that says gold and Sensex are moving at tandem? Well, let's put it to the test. Here I took the period mentioned in the image and compared it to only to the large cap funds exited 14 years before. Using Sensex as a base, anything that delivered better was colored green. Check out the image to see if gold is really in sync with Sensex or not. Fortune Investment Services Pvt Ltd #mutualfundssahihai #mutualfundsindia #financialservices #investment #wealth #SystematicInvestmentPlan #financialadvisor #financialfreedom #financialplanning #financialliteracy #financialgoals #financialindependencejourney #MutualFundsSahiHai #mutualfunds #SipSipHooray #sipwealthcreation Disclaimer: Please note that investing in mutual funds carries market risks. It is important to carefully read all scheme-related documents before making any investment decisions. The information contained in the reports is intended for informational purposes only and should be used solely by the recipient.